-
Aug.202021NEWS
HanAll Biopharma and Daewoong Pharmaceutical Invest $1M USD in Alloplex Biotherapeutics
HanAll Biopharma and Daewoong Pharmaceutical Invest $1M USD in Alloplex Biotherapeutics
-
Jul.282021NEWS
HanAll Biopharma Reports Second Quarter 2021 Results
HanAll Biopharma Reports Second Quarter 2021 Results
-
Jul.222021NEWS
HanAll Biopharma Submits IND for Second Phase 3 (VELOS-3) of HL036 in Dry Eye Disease
HanAll Biopharma Submits IND for Second Phase 3 (VELOS-3) of HL036 in Dry Eye Disease
-
Jul.072021NEWS
HanAll\'s Partner HBM Announces Positive Topline Results from Phase 2 of Batoclimab in MG
HanAll\'s Partner HBM Announces Positive Topline Results from Phase 2 of Batoclimab in MG
-
May.062021NEWS
HanAll Biopharma Reports First Quarter 2021 Financial Results
HanAll Biopharma Reports First Quarter 2021 Financial Results
-
Apr.132021NEWS
HanAll Biopharma Appoints David Hernandez as Vice President of Clinical Development Operations
HanAll Biopharma Appoints David Hernandez as Vice President of Clinical Development Operations